Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Gilead CEO Steps Down | Contract Pharma

What are you searching for?

Sign in
Promotions & Moves

Gilead CEO Steps Down

Milligan to succeed Martin

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

John C. Martin, Ph.D., chairman and chief executive officer of Gilead Sciences, Inc. will step down, effective March 10, 2016, and will assume the role of executive chairman of the company. John F. Milligan, Ph.D., currently president and chief operating officer, will be promoted to chief executive officer and will serve on the board of directors.
 
Dr. Martin joined the company in 1990 and was appointed chief executive officer in 1996. Dr. Milligan also joined Gilead in 1990 and was appointed chief operating officer in 2007 and president in 2008.
 
“John Martin has led Gilead as CEO for the past 20 years, and under his stewardship, the company has developed and delivered therapeutic advancements to millions of people around the world. His legacy is clear – and the vision he has set will continue with his contributions as Executive Chairman,” said John Cogan, Ph.D., Gilead’s lead independent director.
 
“Over the past 25 years, John Milligan has distinguished himself as an exceptional leader, serving in diverse management roles and overseeing multiple phases of growth and expansion into new therapeutic areas and geographies. The Board of Directors and I are confident in his ability to lead Gilead into the future,” said Dr. Martin.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters